EN
HI

Akums Drugs & Pharmaceuticals Share price

AKUMS

422.4

2.50 (-0.59%)
NSE
BSE
Last updated on 20 Nov, 2025 | 10:28 IST
BUYSELL
Today's High

429.20

Today's Low

421.20

52 Week Low

405.00

52 Week High

705.70

The current prices are delayed, login to your account for live prices

Akums Drugs & Pharmaceuticals Chart

Akums Drugs & Pharmaceuticals Share Key Metrics

Volume
17829.00
Market Cap
6687.67 CR
LTQ@LTP
6@422.40
ATP
423.91
Var Margin
17.36 %
Circuit Range
382.45-467.35
Delivery %
67.93 %
Value
75.58 L
ASM/GSM
No
Market Lot
1

Akums Drugs & Pharmaceuticals Fundamentals

View More
P/E Ratio

21.37

P/B Ratio

2.15

Div. Yield

0

Sector P/E

37.9

Sector P/B

3.65

Sec. Div. Yield

0.57

Akums Drugs & Pharmaceuticals Resistance and Support

Pivot 543.68

Resistance

First Resistance

550.36

Second Resistance

559.68

Third Resistance

566.36

Support

First Support

534.36

Second Support

527.68

Third Support

518.36

Akums Drugs & Pharmaceuticals Futures & Options

Data Not Found

Akums Drugs & Pharmaceuticals Shareholding Pattern

View More
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

75.26%

Mutual Fund

5.54%

Insurance

0.67%

Foreign Institutional Investors

6.36%

Domestic Institutional Investors

0.51%

Retail

11.66%

Others

0%

Total Promoters
SEP '24
75.26%
DEC '24
75.26%

Akums Drugs & Pharmaceuticals Corporate Actions

DateAgenda
2025-11-13Quarterly Results
2025-08-08Quarterly Results
2025-05-26Audited Results
2025-02-06Quarterly Results
2024-11-09Quarterly Results
2024-08-24Quarterly Results

Akums Drugs & Pharmaceuticals News

No Data Found

About Akums Drugs & Pharmaceuticals

NSE : 24715  
BSE : 544222  
ISIN : INE09XN01023  

Our Company was incorporated as a public limited company under the Companies Act 1956 as ‘Akums Drugs and Pharmaceuticals Limited’ pursuant to a certificate of incorporation dated April 19 2004 issued by the RoC. Our Company received a certificate for commencement of business issued by the RoC dated May 13 2004.Major Events and Milestones:2004-Incorporation of the Company-Established first plant for oral dosage commissioned at 19 20 21 sector 6A Haridwar Uttarakhand2007-Established dedicated manufacturing site for oral liquid dosage at 22 Sector 6A Sidcul Haridwar Uttarakhand and sterile products at 2345 Sector 6B SIDCUL Haridwar Uttarakhand2009-Incorporated Maxcure Nutravedics Limited to venture into nutraceuticals2010-Dedicated a facility for hormones at 48 Sector 6A SIDCUL Haridwar Uttarakhand-Dedicated a facility for cosmetics and dermatology at 47 Sector 6A SIDCUL Haridwar Uttarakhand-Incorporated Akumentis Healthcare Limited to venture into branded formulations2011-Innovated bi-layered sustained release tablets for the first time2012-Acquired Pure and Cure Healthcare Private Limited to expand capacity and capabilities2013-Innovated tablet-in-tablet sustained release tablets for the first time-Acquired Malik Lifesciences Private Limited manufacturing sites to expand capacity and capabilities-Expanded into the African market2015-Expanded into the Asian market-Established research and development laboratory in Mumbai Maharashtra to venture into regulated market2016-Maxcure Nutravedics Limited received US-NSF certification2019-Investment by Ruby QC Investment Holdings Pte. Ltd. in our Company to become a minority shareholder2021-Acquired Parabolic Drugs to form Akums Lifesciences Limited and ventured into APIs-Acquisition of a facility at Kotdwar Uttarakhand by Akums Healthcare Limited2022-Plant at 19 20 21 Sector 6A SIDCUL Haridwar Uttarakhand and plant at 2 3 45 Sector 6B SIDCUL Haridwar Uttarakhand accredited European Union-Good Manufacturing Practices qualifying for exports to European markets-Acquisition of a facility in Haridwar Uttarakhand by Akums Healthcare Limited and a facility in Baddi Himachal Pradesh by Pure and Cure Healthcare Private Limited2023-Acquisition of another facility in Baddi Himachal Pradesh by Pure and Cure Healthcare Private Limited-Merger of Akums Lifesciences Limited with Pure and Cure Healthcare Private Limited

Read More

Akums Drugs & Pharmaceuticals Management

NamePosition
Mr. Sanjeev Jain Managing Director
Mr. Sandeep Jain Managing Director
View More

Akums Drugs & Pharmaceuticals FAQs

The Buying Price of Akums Drugs & Pharmaceuticals share is 422.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Akums Drugs & Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Akums Drugs & Pharmaceuticals, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Akums Drugs & Pharmaceuticals shares is 21.37. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Akums Drugs & Pharmaceuticals shares is 2.15. Useful to assess the stock's value relative to its book value.

To assess Akums Drugs & Pharmaceuticals’s valuation compare Sector P/E, P/B which are 37.9 & 3.65 with sector averages, along with growth rates and financial metrics.

The Market Cap of Akums Drugs & Pharmaceuticals is 6687.67 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Akums Drugs & Pharmaceuticals share price is 705.70 & 405.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Akums Drugs & Pharmaceuticals belongs to the Healthcare sector.